Scott D Eliasof

Title: Scott D Eliasof: Innovator in Urological Disorder Treatments

Introduction

Scott D Eliasof is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of medical treatments, particularly focusing on urological disorders. With a total of 2 patents, Eliasof's work is paving the way for advancements in diagnosis and treatment methodologies.

Latest Patents

Eliasof's latest patents include innovative methods and compositions for treating urological disorders using a gene identified as Carboxypeptidase Z, referred to as '8263'. This invention relates to the diagnosis and treatment of urological disorders by identifying the differential expression of the '8263' gene in affected tissues compared to normal states. The patent outlines methods for diagnostic evaluation and prognosis of various urological diseases, as well as identifying compounds that can modulate these disorders. Another significant patent focuses on identifying compounds capable of treating pain or painful disorders, which involves combining test compounds with specific polypeptides to detect binding and efficacy.

Career Highlights

Eliasof is currently associated with Bayer Healthcare Aktiengesellschaft, where he continues to innovate and contribute to the medical field. His work is characterized by a strong emphasis on research and development aimed at improving patient outcomes in urological health.

Collaborations

Eliasof has collaborated with esteemed colleagues such as Venkateswarlu Karicheti and Inmaculada Silos-Santiago. These collaborations have further enriched his research and development efforts, leading to impactful innovations in the medical field.

Conclusion

Scott D Eliasof is a prominent inventor whose work in treating urological disorders is making a significant impact. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient care.